CAIRS for keratoconus: Prof Hafezi and Dr. Torres-Netto are featured in Ocular Surgery News, in which CAIRS experts highlight its role in rehabilitating highly irregular corneas.
At the WCC 2025 congress in Washington, DC, Dr. Emilio A. Torres-Netto of the ELZA Institute presented groundbreaking research on ELZA-PACE-CXL, ELZA-sub400 CXL, and Femto-CAIRS, pushing the boundaries of keratoconus treatment.
ELZA’s cornea, cataract, and refractive surgeon, Dr. Emilio Torres-Netto, MD, PhD, FWCRS, was this month appointed by the European Journal of Ophthalmology (EJO) as an Associate Editor. This honor is a reflection of Dr. Torres-Netto’s knowledge, experience, and commitment to the field of ophthalmology.
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
Dr. Emilio A. Torres-Netto has been recognized as a TouchOphthalmology Future Leader 2025 for his groundbreaking work in corneal and refractive surgery.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Dr. Emilio Torres-Netto of the ELZA Institute was awarded the AAO Achievement Award at the 2024 Annual Meeting in Chicago, recognizing his contributions to ophthalmology through education, research, and service.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Dr. Dr. Torres-Netto explained to OSN how ELZA-STARK addresses astigmatism in patients with a history of radial keratotomy (RK).
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
